Target intelligence / Profile preview

MicroRNA 543 (miR-543)

Target
miR-543
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 543 (miR-543) is a small, non-coding RNA molecule that regulates gene expression post-transcriptionally, primarily by binding to the 3'-untranslated region (UTR) of specific mRNAs, leading to their degradation or translational inhibition[2][6][11]. It is transcribed from the MIR543 gene, which is located within the imprinted DLK1-DIO3 region on human chromosome 14[2][6][10][11]. miR-543 plays complex, context-dependent roles in human biology, acting either as an oncogene or tumor suppressor depending on the tissue and molecular environment: In pancreatic, gastric, renal, and oral squamous cell carcinomas, as well as some other cancers, miR-543 typically promotes cell proliferation, invasion, migration, and epithelial–mesenchymal transition, thus facilitating tumor progression.[1][3][4][7][9][12] In contrast, in some contexts such as colorectal cancer and glioblastoma, miR-543 can act as a tumor suppressor, inhibiting proliferation and metastasis by targeting genes like KRAS, MTA1, HMGA2, and ADAM9[5][8][10]. miR-543 is implicated in a broad range of systemic and organ-specific diseases, functioning as part of a complex non-coding RNA network affecting cell fate, EMT, apoptosis, and more[2][6]. miR-543's diversity of direct mRNA targets and variable regulatory effect make it a promising but complex potential biomarker and therapeutic target in oncology and other diseases[2][5][6]. However, as with many miRNAs, translation into clinical applications remains limited by delivery challenges, potential pleiotropic effects, and incomplete understanding of its broader role in normal physiology and disease[2][6].

Other names
hsa-miR-543MIRN543mir-543MIR543hsa-mir-543
02

Mechanism of action

Inhibition or restoration of miR-543 expression to modulate gene expression of its targets (e.g., targeting oncogenic or tumor suppressor pathways). It targets specific mRNAs such as SPOP, ADAM9, KRAS, MTA1, HMGA2, FAK, TWIST1, PTEN, PAQR3, SIRT1, PRMT9, CYP3A5, and DKK1, resulting in respective downstream effects in cell functions, proliferation, migration, and apoptosis

03

Biological functions

Regulation of gene expressionCell proliferationCell cycle regulationApoptosisCell migrationCell invasionEpithelial–mesenchymal transition (EMT)Other
04

Disease associations

Cancer (including pancreatic, cervical, ovarian, colorectal, gastric, renal, oral squamous cell carcinoma, glioblastoma, and endometrial cancers)Noncancerous diseases (e.g., involvement in respiratory, digestive, gynecologic, obstetric, and nervous system diseases)
05

Safety considerations

Safety concerns relate mainly to the challenge of specifically modulating miR-543 therapeutically, with potential for off-target effects and disruption of normal gene regulatory networks.
06

Interacting drugs

None reported; as a microRNA, direct small molecule or biological drug interactions are rare, but RNA therapeutics and gene editing approaches may target or mimic miR-543
07

Biomarkers

Diagnostic and prognostic biomarker potential identified for renal cell carcinoma, colorectal cancer, oral squamous cell carcinoma, glioblastoma, and possibly other tumorsPrognostic biomarker in glioma, negatively correlated with tumor gradeIts expression can indicate EMT status and tumor aggressiveness

Beyond the preview

Go deeper on MicroRNA 543 (miR-543).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 543 (miR-543).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call